Skip to main content
VCbacked
Log inGet Started

InVera Medical

Galway, Ireland

InVera Medical is an innovative medical device company developing the next-generation treatment for all chronic venous disease patients.

$2.7M raised
Mar 2022
Grant
Health CareMedical Device

Top Investors

Enterprise IrelandEuropean Innovation CouncilNipro CorporationMedTech InnovatorWestern Development Commission

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about InVera Medical

How much funding has InVera Medical raised?
InVera Medical has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in March 2022.
Who are InVera Medical's investors?
InVera Medical's investors include Enterprise Ireland, European Innovation Council, Nipro Corporation, MedTech Innovator, Western Development Commission.
Where is InVera Medical headquartered?
InVera Medical is headquartered in Galway, Ireland.
What does InVera Medical do?
InVera Medical is an innovative medical device company developing the next-generation treatment for all chronic venous disease patients.
What stage is InVera Medical at?
InVera Medical is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"InVera Medical — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/invera-medical. Accessed July 2, 2026.
APA
VCBacked. (2022). InVera Medical — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/invera-medical
Wikipedia (cite web)
{{cite web |title=InVera Medical — Funding & Investors |url=https://www.vcbacked.co/company/invera-medical |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
Rapport Therapeutics
Boston$250.0M
YLAH
Bern$589K
Novostia
Epalinges$6.6M